The French President, Emmanuel Macron, visited a laboratory Sanofi Tuesday, alongside chief executive Paul Hudson, and announced 200 million euros of public investment for reducing France “s dependence on other countries for vaccines and other medicines.Macron said France will “relocate” the production of certain drugs in the wider context of the government’s efforts to revive the virus from the battered economy and bring more manufacturing production in France.
Last month, Sanofi prompted outrage in France, promising to give the united States the first access to the company “s future vaccine, because the U.S. has invested more in its research. Sanofi later, backtracked and said that it would be available in all countries.
Macron has pushed for vaccines to be regarded as a “common good” of humanity, which should not be subject to market pressures.
The Imperial vaccine uses synthetic strands of genetic code based on the virus. Once injected into the muscle, the body “s own cells are encouraged to make copies of a spike protein on the sars coronavirus. That should in turn trigger an immune response so that the body can fight off any future COVID-19 infection.
Dr Doug Brown, chief executive of the British Society for Immunology, said that the technology used by the Imperial College of London, in theory, should lead to long-term immunity against the sars coronavirus, but must now go through strict testing. It was not related to the trial.
The University of Oxford, has recently undertaken an advanced study involving 10,000 volunteers, and the UNITED states is preparing for yet more studies in July, which involved 30 000 people each test of the various candidates, including Oxford “s and the one made by the National Institutes of Health and the Moderna Inc.
Scientists have never created a vaccine from scratch, quick and it is far from clear that everything will eventually prove to be safe and effective. Yet, many countries, including Britain, France, Germany, the netherlands and the UNITED states, have already placed orders in advance for millions of vaccines.
Shattock said the Imperial vaccine, if effective, would not be authorized to use any specific pharmaceutical, but various manufacturing partners around the world would be given permission to produce in the framework of a “social business” which does not make profits.
“We can “provide, without charge, because it takes money to do that,” he said. “We will provide the cost of goods with a small percentage —and this small percentage varies in function of the economic situation of the country.” The World Health Organization noted Monday, about 100 000 new infections have been reported every day for the past two weeks, and that relaxed lock restrictions in many countries, have led to a new outbreak of cases. (AP) RS RS
Warning :- This story has not been edited by Outlook staff and is self-generated from the news agency rss. Source: PTI
More from Outlook Magazine